STRS Ohio’s Xeris Biopharma Holdings XERS Stock Holding History

STRS Ohio’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$170K	Buy	21,500 +3,900	+22%	+$24.9K	﹤0.01%	1666
2026 Q1	$102K	Sell	17,600 -47,900	-73%	-$318K	﹤0.01%	1773
2025 Q4	$514K	Hold	65,500	–	–	﹤0.01%	1072
2025 Q3	$533K	Hold	65,500	–	–	﹤0.01%	1051
2025 Q2	$306K	Buy	65,500 +4,600	+8%	+$21.1K	﹤0.01%	1501
2025 Q1	$334K	Sell	60,900 -2,200	-3%	-$8.88K	﹤0.01%	1355
2024 Q4	$214K	Sell	63,100 -4,300	-6%	-$13.8K	﹤0.01%	1479
2024 Q3	$192K	Hold	67,400	–	–	﹤0.01%	1569
2024 Q2	$152K	Buy	67,400 +6,900	+11%	+$13.9K	﹤0.01%	1622
2024 Q1	$133K	Sell	60,500 -3,800	-6%	-$9.83K	﹤0.01%	1642
2023 Q4	$151K	Hold	64,300	–	–	﹤0.01%	1633
2023 Q3	$119K	Hold	64,300	–	–	﹤0.01%	1679
2023 Q2	$168K	Buy	+64,300	New	+$164K	﹤0.01%	1627
2021 Q2	–	Sell	-300	Closed	-$1K	–	2447
2021 Q1	$1K	Hold	300	–	–	﹤0.01%	2163
2020 Q4	$1K	Hold	300	–	–	﹤0.01%	2150
2020 Q3	$1K	Hold	300	–	–	﹤0.01%	2176
2020 Q2	$0	Hold	300	–	–	﹤0.01%	2265
2020 Q1	$0	Hold	300	–	–	﹤0.01%	2103
2019 Q4	$2K	Hold	300	–	–	﹤0.01%	2043
2019 Q3	$2K	Hold	300	–	–	﹤0.01%	2061
2019 Q2	$3K	Hold	300	–	–	﹤0.01%	2097
2019 Q1	$3K	Hold	300	–	–	﹤0.01%	2035
2018 Q4	$5K	Sell	300 -1,600	-84%	-$32.1K	﹤0.01%	2051
2018 Q3	$33K	Buy	+1,900	New	+$41.2K	﹤0.01%	1995

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

STRS Ohio's XERS Position: Q2 2026 in Review

STRS Ohio increased its Xeris Biopharma Holdings (XERS) stake by 22% in Q2 2026, buying an estimated $24.9K and bringing the position to 21,500 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

STRS Ohio first reported a position in XERS in Q3 2018 and has held it in 24 quarters since. The position peaked at $533K in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

STRS Ohio held 21,500 shares of Xeris Biopharma Holdings worth $170K as of Q2 2026.
STRS Ohio bought 3,900 Xeris Biopharma Holdings shares in Q2 2026, an estimated $24.9K.
Xeris Biopharma Holdings made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1666 holding.
STRS Ohio first reported a position in Xeris Biopharma Holdings in Q3 2018 and has held it in 24 quarters since.
STRS Ohio's Xeris Biopharma Holdings position peaked at $533K in Q3 2025.
241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.